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Abstract

Medication errors and adverse drug reactions are prevalent across the healthcare continuum.
As many as 4.6% of deaths in the United States may be the result of an adverse drug reaction,
making them one of the top five leading causes of death. Accurate medication reconciliation is
one method to help protect patients from adverse medication reactions. Medication
reconciliation is a formal process that is used by health care providers to gather a complete and
accurate medication list to identify discrepancies, inform prescribing decisions and identify and
prevent medication errors. This DNP project involved the implementation of an evidence-based
medication reconciliation protocol with a sample of twenty-five patients at a community-based
outpatient psychiatric practice in Western Massachusetts. Results indicated that there were a
significant number of both prescribed and over the counter medications missing from the
patient’s electronic medical record medication profile as well as a high number of potential drug
interactions. Staff education about the process of medication reconciliation was an important
aspect of this project.
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Medication Reconciliation in an Ambulatory Care Community Mental Health Practice
Whether admitted to an inpatient facility or as an outpatient in a medical practice, the
importance of maintaining accurate medication lists cannot be understated. With the majority of
medication, errors occurring during transitions of care between providers (Nassaralla, et al.,
2008) patients in outpatient practices are left vulnerable to errors. Psychiatric patients are
particularly susceptible as it not uncommon for them to be on combinations of both psychiatric
and general medical drugs to treat both mental illness as well as comorbid medical conditions
(Simoons, et al., 2016).
Background
Adverse Drug Events
Medication errors and their potential associated adverse drug events are a serious
problem in acute care facilities, skilled nursing facilities, provider practices and in the home.
Adverse drug events (ADE) account for nearly 700,000 emergency department visits and
100,000 hospitalizations each year, and they affect nearly five percent of hospitalized patients
which makes them one of the most common types of inpatient errors. Due to lack of structured
reconciliation processes, ambulatory patients may experience ADEs at even higher rates (Agency
for Healthcare Research and Quality [AHRQ], 2015). Adverse drug reactions cost $136 billion
yearly which is an amount that is greater than the total costs of cardiovascular or diabetic care
(U.S. Food and Drug Administration, 2016). The highest risks for discrepancies occur during
discharge from acute care facilities to home where studies estimate that anywhere from 14.1% to
94% of patients experience at least one medication discrepancy (Fuji, M, & Abbott, 2014). As
many as 4.6% of deaths in the United States may be the result of an adverse drug reaction,
making them one of the top five leading causes of death (Bourgeois, Shannon, Valim, & Mandl,
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2010).
With lengths of stay in U.S acute care hospitals steadily decreasing since 1960 (Kalra,
Fisher, & Axelrod, 2010), the reliance on outpatient providers for disease management and
prescribing has increased. More than 80% of adults in outpatient settings report using at least
using one medication, and approximately 70% of outpatient clinic visits in the United States
have been associated with the prescription or continuation of a medication. In addition, the
proportion of patients taking five or more medications more than doubled between 1995 and
2005 (Bourgeois et al., 2010).
With increasing use of prescription medications, polypharmacy as well as an increasing
elderly population (ADEs have increased among patients 65 years and older with as many as one
in twenty persons seeking medical care for an ADE), the potential risk of ADEs has also
increased. Findings from an 11-year national study on adverse drug events revealed that overall,
outpatient adverse drug reactions resulted in a mean yearly total of 107,468 hospital admissions.
Therefore, measures must be developed to monitor and prevent ADEs in the outpatient
population (Bourgeois et al., 2010).
Barnsteiner (2008) summarized findings from two studies that addressed discrepancies in
outpatient medical records: Among the findings, one study reflected discrepancies in 26.3% of
charts of patients who were requesting precription medications; of those, 59% involved omitted
medications from the electronic list. A second study in an ambulatory family practice found that
among the 76% of patients in the practice who had medications prescribed, 87% of the charts
had incomplete or missing documentation of those medications.
As mentioned previously, psychiatric patients are particularly susceptible to medication
errors. In a study of medication reconciliation, Simoons, et al., (2016) found at least one
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discrepancy in 94.8% of patients among four outpatient departments for mood and anxiety
disorders with almost twenty-three percent of all discrepancies having the potential to cause
“moderate to severe discomfort or clinical deterioration, affecting almost half of all patients” (p.
1516).
Medication Reconciliation
The Institute of Medicine (2001) defined The Six Domains of Health Care Quality, and
one of those aims was that health care must be safe. Providing safe care involves avoiding harm
to patients from the care that is intended to help them (AHRQ, 2001). Accurate medication
reconciliation is an essential process in helping protect patients from adverse drug events and
keeping patients safe. Medication reconciliation is such an important process that the World
Health Organization named it as one of five top patient safety strategies (McCarthy, et al., 2016).
Medication reconciliation is a formal process that is used by health care providers to
gather a complete and accurate medication list (both home and prescribed) to identify
discrepancies, inform prescribing decisions and identify and prevent medication errors (AHRQ,
2013). The design of medication reconciliation centers around the concept of creating a single
list of the patient’s current list of medications which AHRQ (2012), describes as the "one source
of truth." that can be accurately shared and utilized by all physicians, nurses, pharmacists, and
others caring for the patient. “The reconciling process has been demonstrated to be a powerful
strategy to reduce medication errors as patients move from one level of care to another” (IHI,
2011, p. 6).
When medication reconciliation cannot be performed in the medical office, it may be
necessary to execute it in the patient’s home. This is especially important when a patient is
homebound due to multiple medical comorbidities. Fuji, M, & Abbott (2014) suggest that when

MEDICATION RECONCILIATION

8

medications have to be reconciled in the home, a timeline should be set for completion of the
process, a time should be set for when the process shall occur, a checklist and forms should be
created as needed to guide the process.
Problem Statement
Medication errors and adverse drug events (ADE) cost billions of dollars a year, lead to
readmissions and increased lengths of stay, and most importantly, cost patient lives. The risk of
adverse outcomes increases with absent, incomplete or inaccurately completed medication
reconciliations. The quality improvement project proposed, involves the implementation of an
evidence-based protocol to improve the process of medication reconciliation in an outpatient
psychiatric practice.
Organizational “Gap” Analysis of Project Site
The location for this quality improvement project was a community-based outpatient
psychiatric practice in Western Massachusetts where the majority of patients are adults, many of
whom have comorbid medical conditions. The current medication reconciliation process at this
practice is inefficient. Licensed Social Workers (LICSW) and therapists collect medication
information when they complete an initial intake with a patient in the office or on subsequent
visits in the patient’s home. Most of the social workers and therapists have no medical
background and thus, do not always put much emphasis on the mediation reconciliation portion
of the intake. Social workers and therapists also have no training in the area of pharmacology, so
it’s difficult for them to identify, properly categorize or select the correct formulation of each
medication in the list (caps, pills, liquid). If a medication list is incomplete on the first visit to a
practice, if it is not reconciled correctly on a subsequent visit, the medical record remains
incorrect and opens a patient up to the potential risk of adverse outcomes.
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Review of the Literature
Databases and sites searched in this literature review (see Appendix C) included
CINAHL, PubMed, Agency for Healthcare Research and Quality (AHRQ) and Institute for
Healthcare Improvement (IHI). Keywords used included medication reconciliation, outpatient,
psychiatric, ambulatory care with inclusion criteria 2008-2017 and English language. For
purposes of this draft, five studies and two evidence-based protocols were chosen from the IHI
and the AHRQ.
Nassaralla, et al., (2008) and (Keogh, et al., 2016) conducted studies based on the
implementation of interventions to improve medication reconciliation completion compliance in
ambulatory care settings. Nassaralla, et al., (2008) implemented their intervention and conducted
their study across four academic, ambulatory primary care clinics. Before the intervention,
baseline data that assessed the completeness, correctness and accuracy of medication
documentation in the electronic health record (EHR). Interventions that included staff training
and patient education to increase awareness were implemented. Completeness of medication
lists improved from 20.4% pre-intervention to 50.4% post-intervention, and patient participation
in the medication reconciliation process increased from 13.9% to 33%; lastly, medication list
accuracy improved from 11.5% to 29%.
Keogh, et al., (2016) implemented a 24-month medication reconciliation improvement
process across 148 ambulatory care practices in one health care system. Three levels of
interventions that centered on staff education were implemented; a more intensive intervention
was implemented at 65 specialty practices; a modified approach was implemented at 71 other
specialty practices, and a less intensive approach was used at 14 primary care practices. The
level of intervention varied based on practice infrastructure and prescription rates. Two
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measures were used: measure one, the percentage of active medications prescribed by that
provider that were reconciled and measure two, how often all medications that were prescribed
by the provider were reconciled. From pre to post-intervention, measure one improved from
71% to 90% in specialty practices and from 62% to 91% in primary care practices. Measure two
across all ambulatory practices increased from 81% to 90%. All interventions, which focused
heavily on staff education as well as better informing patients about the medication
reconciliation processes, showed improved outcomes.
Milone, Philbrick, & Harris, (2014) included a pharmacist in their intervention in
determining the incidence of medication discrepancies in the EHR of an outpatient family
medical clinic. Before seeing the physician, the clinical pharmacist consulted with each patient
and reviewed their medication list and made corrections as necessary. During the one-year study
period, a total of 327 patients were seen by the pharmacist for reconciliation, and 2,167
discrepancies were identified and resolved. Of the discrepancies found, 51.1% were determined
to be clinically important by the pharmacist. This study highlights the benefits of including a
clinical pharmacist in the medication reconciliation process in outpatient practices.
Sarzynski, Luz, Rios-Bedoya, & Zhou, (2014) conducted a pilot study using a ‘brown
bag’ method to improve the medication reconciliation process. Forty-six cognitively intact
elders at a university-affiliated community practice were the subjects. Half of the participants
were asked to ‘brown bag' (bring their medication bottles with them to the appointment), and the
other half were ‘non-brown baggers.' Results showed that most of the ‘brown baggers' did not
bring all their medications to their appointment, therefore, chart list accuracy was no better for
‘brown baggers' vs. ‘non-brown baggers.' The authors suggest that bringing medications may
prompt providers to conduct a more thorough medication history; however, regardless of
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bringing medications to office visits, structured interviewing is a more accurate way to reconcile
medications than using chart lists; ‘brown bag requests' should be combined with structured
interviewing.
Vejar, Makic, & Kotthoff-Burrell (2014) conducted a more successful ‘brown bag’
quality improvement project. During a 9-month period in a primary care setting that serves a
patient population from ages 51 to 102, a pre and post intervention to improve medication
reconciliation was conducted. A key facet of the intervention was ‘brown bagging' or having the
patients bring all of their prescription and over the counter medications to every visit. Baseline
data for patients who ‘brown bagged' their medications before the intervention was zero percent
and post-intervention was 64%.The pre-intervention medication reconciliation rate was 64%, and
post-intervention rose to 96%. Educating patients and staff played a significant role in
increasing reconciliation rates; the most effective tools included reminder notes posted in exam
rooms for patients, monthly discussions with employees about compliance rates and automated
phone reminders for patients to bring their medications to their visit.
The Institute for Healthcare Improvement (IHI) How-to Guide: Prevent Adverse Drug
Events by Implementing Medication Reconciliation is an evidence-based protocol for
implementing a medication reconciliation process at all transitions’ of care, including admission,
transfer, discharge and ambulatory sites. Based on Johns Hopkins Nursing Evidence Based
Practice (JHNEBP) evidence rating scales (Newhouse, Dearholt, Poe, LC, & White, 2005) the
strength of evidence is level 4, and quality of evidence is A. This guideline advises on how to
Conduct Medication Reconciliation Reviews, complete the medication reconciliation, reconcile
differences as well as dealing with barriers.
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The Agency for Healthcare Research and Quality (AHRQ) Medications at Transitions
and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation is an evidence-based
toolkit based on processes developed in acute-care settings but with core processes, tools, and
resources can be adapted for use in non-acute facilities. (Gleason KM, 2012). Based on
JHNEBP evidence rating scales (Newhouse, Dearholt, Poe, LC, & White, 2005), the strength of
evidence is level 4, and quality of evidence is A. The toolkit is a blueprint for developing a
medication reconciliation process in order to gain a single, accurate list of patient medication that
is referred to as, "the one source of truth" (p. 22).
Evidence-Based Practice: Verification of Chosen Option
The AHRQ Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for
Medication Reconciliation and the IHI How-to Guide: Prevent Adverse Drug Events by
Implementing Medication Reconciliation will be used to provide a framework for developing a
medication reconciliation process at a community-based outpatient psychiatric practice.
Theoretical Framework/Evidence-Based Practice Model
Lippitt’s Phases of Change Theory (Mitchell, 2013), an extension of Lewin’s Three-Step
Change Theory, will be used as a theoretical guide for this quality improvement project (see
Appendix A). Lippitt’s phases of change theory is commonly used in the nursing profession and
focuses on the role and responsibility of change agent than the change itself; external change
agents effect a change, the change agent relationship ends and in their place is the foundation for
change to move forward (Anderson, 2015). The four elements of Lippitt’s Theory are
assessment, planning, implementation, and evaluation, all of which parallel the steps of the
nursing process (assessment, diagnosis, outcomes/planning, implementation, evaluation) and
therefore, lend themselves well to this quality project. Within the four elements of Lippitt’s
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Theory are seven phases that guide change:
•

Phase one: diagnose the problem

•

Phase two: assess motivation/capacity for change

•

Phase three: assess change agent’s motivation and resources

•

Phase four: select progressive change objective

•

Phase five: chose appropriate role of the change agent

•

Phase six: maintain change

•

Phase seven: terminate the helping relationship (Mitchell, 2013)

As Melat-Ziegler (2005) explains, the seven phases “do not possess rigid boundaries, rather
movement may flow back and forth between the phases” (p. 204). The steps in Lippitt’s Theory
were used as a guide in implementing this DNP project.
Lippitt’s Seven Phases
In the first three phases, change agents (management, practitioners) expressed their
motivation to change, after they were made aware of the reasons (need) for change. Through
collaboration, the problems were identified, and the process of change was explained. In phases
four through six, change objectives in the reconciliation process were selected, the nurse’s (DNP
student) role in the process was defined, and the change was initiated. In the seventh and final
phase, after successful integration of the change, the nurse implemented strategies to maintain
the changes. This final phase corresponds with Lewin’s ‘refreezing’ stage at which point, after
finding a new way of doing things is established, changes are made permanent (Mitchell, 2013)
(Melat Ziegler, 2005).
Goals, Objectives and Expected Outcomes
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With the assistance of management and staff, an evidence-based medication
reconciliation project was implemented by DNP student

•

The goal was a 50% medication reconciliation completion rate

•

The intervention took place over a 2-month period during the months of December, 2017
and January, 2018

•

After analysis of results, the objective was for an evidence-based medication
reconciliation process to stay in place at the practice
Project Design
Using a stepwise approach, the AHRQ Medications at Transitions and Clinical Handoffs

(MATCH) Toolkit for Medication Reconciliation and the IHI How-to Guide: Prevent Adverse
Drug Events by Implementing Medication Reconciliation, with a focus on ambulatory care,
guided the implementation of this practice intervention. The current medication reconciliation
process was inefficient, therefore, this evidence-based quality improvement project aimed to
improve patient safety through its initiation.
Project Site and Population
The project site for this quality improvement project was an ambulatory care, community
mental health practice in Western Massachusetts that provides outpatient psychiatric services
including psychotherapy, medication management, substance abuse treatment and crisis
intervention for children to senior citizens. Being a community practice, a significant portion of
the clientele have state or federal sponsored (Medicaid and Medicare) insurance. The practice
served a total of 932 outpatient clients and 371 family stabilization clients in the past year.
Compliance with scheduled appointments is an issue at this practice. There is a small,
core group of patients who either cancel their appointment with the medication provider at the
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last minute or skip (no-show) their appointments all together. Compliance with medication
provider appointments was a hindrance to completing the medication reconciliation in office.
Participants
Education on the medication reconciliation process was provided to all supervisory staff
and to all participants. Participants who had appointments with the medication provider during
the months of October and November, 2017 were asked if they are willing to participate in a
medication reconciliation quality improvement project. Upon approval, they were asked to bring
medications (prescribed and OTC) and medication lists to a subsequent appointment so they may
be reconciled. Those who were not available during an appointment time were contacted by
phone to inquire about their participation. The end sample included twenty-five total patients.
All participants were adults, over the age of 18. Due to the potential for multiple medications
being prescribed and an increased risk of inaccurate medication lists, emphasis was be placed on
older patients (50+) with comorbid medical conditions.
Setting facilitators and barriers
Facilitators to the implementation of this quality improvement project included the
willingness of management and staff to help initiate, facilitate and participate; including, the
clinic director, an advanced nurse practitioner, and three outpatient therapy supervisors. The
clinic director oversaw and approved all aspects of project implementation. Three outpatient
supervisors provided feedback on the current process, helped with patient selection and provided
feedback. The nurse practitioner provided assistance, as needed, in recruiting patients for the
intervention. Barriers to implementation included patient refusal to participate, medication
noncompliance, appointment non-compliance, inability to obtain medication lists from other
providers and the overall increased probability of noncompliance in the psychiatric population.
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Implementation Plan/Procedures
•

Approval was obtained from site clinic director

•

Institutional review board (IRB) approval was obtained

•

Coordinated with staff, identified team members and established roles

•

Goals and objectives determined

•

Timeline developed (Appendix E)

•

Flow chart for medication reconciliation process created(Appendix D)

•

Form created for taking medication histories (Appendix B)

•

Implementation strategy developed

•

Education provided to staff

•

Review patient databases/records for selection

•

Patient participant list created

•

Patient participation requested

•

Reminders sent to patients to bring medications and lists to visit

•

Releases of information (ROI) updated as necessary

•

Patients interviewed, medication bottles and lists reviewed

•

Medication information obtained from outside as necessary (providers/pharmacies)

•

Patient provided with updated and completed medication list (Appendix B)

Measurement Instruments
In order measure the outcomes of this DNP project, pre and post medication
reconciliation data was recorded to include:
Qualitative data:
•

Patient gender
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•

Patient age

•

Brought medications for reconciliation (y/n)

Quantitative data:
•

Number of no-show appointment in the previous year

•

Number of psychiatric medications

•

Number of non-psychiatric medications

•

Number of over the counter medications

•

Number of potential drug interactions total

•

Number of potential drug interactions between those medications that were in the
medication profile with the number of medications that were not in the medication profile

Data Collection Procedures
The Plan-Do-Check-Act (PDCA) Cycle guided this quality project. The Plan-Do-StudyAct (PDSA) cycle, part of the IHI Model for Improvement, is a tool for accelerating quality
improvement by planning it, trying it, observing the results, and acting on what is learned
(AHRQ, 2013). The plan stage is recognizing an opportunity and planning a change. The do
stage involves testing the change and carrying out a small-scale study. The check stage involves
reviewing the test, analyzing the results and identifying what was learned. The act stage involves
taking action based on what was learned and if the change did not work, going through the cycle
again with a different plan. If the plan was successful, incorporating what was learned into wider
changes and using what was learned to plan new improvements then beginning the cycle again
(American Society for Quality, 2017).
Steps
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After this DNP student had been seeing patients in the practice for over a year, it was
apparent that EMR’s were not up to date with the most current medications and that the practice
of mediation reconciliation was either inadequate or all together, absent. It was at that time that
this DNP project was conceived and brought to the attention of the clinic director.
Team selection
After assessing the needs and motivation to change, meetings were held with the clinic
director, the outpatient therapy supervisors, therapists and nurse practitioner to discuss
medication reconciliation as a process and to discuss the importance of keeping the EMR up to
date with current medications. Separate meetings were held with the practice’s compliance
officer and Information Technology (IT) representative and the Manager of Integrated Services.
Discussion was held with Manager of Integrated Services about potentially having a compliance
report created for completion of the medication reconciliation process as well as a standardized
electronic medication reconciliation form to be completed by the admitting clinician.
Discussion was held with IT officer requesting to have more providers listed in the drop
down list of prescribers; as the current system is built, the only providers who can be chosen are
those who work for the organization. Other providers must be listed in a free text field that is not
visible unless a ‘+’ sign is clicked. Meetings with supervisors included discussion about the
process of medication reconciliation, the plans for the intervention as well as discussion about
potential patients to be selected.
Intervention
The patient population at the practice ranges from children as young as four to adults as
old as seventy-five. Although a large percentage of the patient population are only being
prescribed psychiatric medications from the nurse practitioners in the practice, many of the older
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adults have comorbid medical conditions and are on more than one medication from their
medical providers; this was the population targeted for this intervention. Thirty-five patients
were selected to have their medications reconciled as per the AHRQ and INH Guidelines.
During provider visits, the importance of maintaining updated medication lists was explained
and selected patients were asked to participate in this intervention. Additional patients were
contacted by phone. The initial plan was to have all patient’s medications reconciled in the
office.
The reconciliation process began as an in-office intervention but due to appointment noncompliance, extended to home visits. In office or in home, prescription medication bottles were
reviewed as well as over the counter medications. Medication lists in the EMR were updated
and release of information (ROI) were signed for primary care and specialty practices, as
necessary. Calls were placed to providers and pharmacies as necessary. Patients were provided
with medication lists and they were faxed to primary care practices as necessary. For reasons
including appointment non-compliance and inability to coordinate, by the end of intervention,
twenty-five patient’s medication profiles were updated (71%) in the EMR.
Data Analysis
Statistical Package for the Social Sciences (SPSS) version 24 was used for data analysis
of the measurement instruments described previously.
Cost-Benefit Analysis/Budget
This DNP project was executed almost exclusively by this DNP student. Meetings with
staff were conducted during normal operating hours and in most cases, during the course of
already scheduled meetings.
Timeline

MEDICATION RECONCILIATION

20

The timeframe for this intervention was from September, 2017 through April, 2018 (see
Appendix E). University of Massachusetts Amherst institutional review board (IRB) approval
was sought in September 2017, and participant selection took place in October and November,
2017. Implementation and data collection took place during the months of December, 2017
through January 2018. Data analysis and completion of the final report will took place during
the months of February and March, 2018.
Ethical Considerations/Protection of Human Subjects
Although the behavioral health practice does not currently use a formal medication
reconciliation process, review of medications is part of every assessment or reassessment visit to
the practice. Since the collection of prescribed medication information is already part of a
standard office visit, it is a service that is covered by the Health Insurance Portability and
Accountability Act (HIPAA). Since this intervention will take place as a matter of routine
during office visits, it too will be covered by the same HIPAA practices and will introduce no
further risk of harm to patients. All current HIPAA practices at the practice will continue to be
followed and patient data will be kept secure and protected. In September, 2017, it was
determined by of University of Amherst, Office of Research Compliance, that this DNP project
did not meet the definition of human subject research thus, IRB approval and participant consent
was not required.
Results
Pre-intervention Descriptive Statistics
Sample
The final sample population for this DNP project included 25 adults, from a behavioral
health practice in Western Massachusetts. The majority of whom have comorbid medical
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conditions and with a mean age of 54 years (SD=5.1). The sample included 20 females (80%)
and five males (20%).
Patient Compliance
Patient compliance was evaluated using two methods. Initially, a patient was considered
compliant if they brought in their medications as instructed for the medication reconciliation.
Patient compliance was also evaluated by examining the number of times they did not show up
(“no-show”) for their provider visit.
Intervention compliance. Of the 25 total subjects, 12 (48%) brought their medications to
their provider visit as instructed. Just over one-half (52%) did not bring in their medications.
This led to extending the intervention to a home visit for 13 patients so that medications were
reconciled in their homes.
Appointment compliance. The total number of no-show visits in the previous 12-months
for all 25 subjects was 39 missed appointments. Of the 13 subjects who had their medications
reconciled in the home, the mean number of “no-show” visits were 2.2 (SD = 1.1). The mean
number of “no show” visits among those who did bring in their medications was significantly
less with a mean of 0.8 (SD = 0.9, t = 3.4, p = 0.002).
Medication Reconciliation
As discussed in the intervention section, both prescription and over-the-counter
medication bottles were reviewed and medication lists in the electronic medical record were
updated based on this reconciliation process. Paired sample T-tests (See Table 1) were
performed to compare pre and post medication reconciliation differences between psychiatric
medications, non-psychiatric medications and over-the-counter medications. Results indicated
that there was a significant difference between pre and post over-the-counter medications
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(mean=2.28) and a very significant difference between pre and post non-psychiatric medications
(mean=4.52).

Table 1. Pre and post medication reconciliation paired sample statistics
Medications
Psychiatric
Pre reconciliation
Post reconciliation
Non-Psychiatric
Pre reconciliation
Post reconciliation
OTC
Pre reconciliation
Post reconciliation

N

Mean

SD

t

p

25
25

2.8
3.0

1.2
1.4

1.4

0.185

25
25

0.4
4.5

0.6
2.8

8.2

<0.001***

25
25

0.0
2.3

0.0
2.5

4.6

<0.001***

†p ≤ .10. *p ≤ .05. **p ≤ .01. ***p ≤ .001
Drug Interactions
Post medication reconciliation analysis used ANOVA to determine statistical differences
between compliance groups (see Table 2). Results indicated that the 12 in-office subjects had a
mean of 3.4 non-psychiatric and 2.4 OTC medications missing from their EMR; those 13 who
had their medications reconciled in home had a mean of 5.5 non-psychiatric and 2.2 OTC
medications missing from their EMR. There was clinical significance (p= 0.052) between the inoffice and home visit compliance group with reconciled non-psychiatric medications with a
mean of 5.5 medications among the home group and 3.4 among those that brought in their
medications with a large effect size (0.82) supporting that many non-psychiatric medications are
not accounted for in the medication profiles of patients.
Results further indicated that those who had their medications reconciled in home had a
total higher risk (mean=1.5) of potential medication interactions. Although under-powered
(would need N=62 to be a statistically significant result) the large effect size of 0.72 (based on
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Cohen’s d), when comparing drug interactions between those who did and did not bring their
medications to office for reconciliation, indicates a result that is clinically significant.

Table 2. Post Med Reconciliation Analysis by Compliance Group
Medication Type Compliance Group

N

Mean

SD

Reconciled nonpsychiatric
medications
Reconciled
psychiatric
medications
Reconciled OTC
medications

12
13
25
12
13
25
12
13
25
12
13
25
12
13
25

3.4
5.5
4.5
2.7
3.2
3.0
2.4
2.2
2.3
0.6
1.5
1.0
0.3
0.5
0.4

2.8
2.4
2.8
1.4
1.4
1.4
3.2
1.6
2.5
0.9
1.5
1.3
0.8
1.4
1.1

Potential drug
interactionstotal
Potential drug
interactionsdrugs not in
EMR

1 (brought)
2 (home)
Total
1
2
Total
1
2
Total
1
2
Total
1
2
Total

F

p

d

4.192

0.052

0.82

1.015

0.324

0.40

0.068

0.797

0.10

3.242

0.085

0.72

0.202

0.657

0.18

Clinical Relevance
Overall, patients who did not bring their medications to the office for reconciliation had
more appointment no-shows and had a higher potential for drug interactions; this sub-group was
also prescribed more medications and used more OTC medications, overall. This could be a
significant finding in treating a vulnerable population such as behavior health patients. Whether
homebound due to medical health issues, mental health issues, substance abuse issues,
inadequate finances (transportation) or other, they may be at higher risk for adverse outcomes.
This highlights the potential need for home health interventions, including medication
reconciliation.
Discussion
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Through this intervention, a 71% medication reconciliation completion rate was
achieved; more than the 50% goal that was set. Results reflected that each patient had at least
one medication missing from their EMR and that overall, there were a significant number of
medications missing. After medication reconciliation was completed:
•

A total of 103 (mean 4.1) additional non-psychiatric medications were entered into the
medication profiles; this increased the total number of psychiatric medications in the
medication profile for all patients from 10 to 113 (see Table 3).

Table 3. Pre and post medication reconciliation non-psychiatric medications

•

A total of 57 (mean 2.3) over the counter medications (OTC and supplements) were
entered into the medication profiles; this increased the total number of OTC medications
in the medication profile for all patients from 0 to 57 (see Table 4).

Table 4. Pre and post medication reconciliation OTC
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Those 12 who brought their medications to the office for reconciliation had a mean of
3.42 non-psychiatric medications and 2.42 OTC medications missing from their
medication profiles.

•

Those 13 who had their medications reconciled in the home with a mean of 5.54 nonpsychiatric medications and 2.15 OTC medications missing from their medication
profiles (see Table 5). .

Table 5. Mean difference between in office and in home reconciliation
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Potential Drug Interactions:
As discussed previously, medication errors and adverse drug interactions are of particular
concern in healthcare today. In light of that, it was of particular interest that through this
intervention, several potential drug interactions were identified. In all, 26 potential drug
interactions were identified; eleven of those were between medications already in the medication
profile with those not in the medication profile.
•

Those 13 who had their medications reconciled in the home had a mean of 1.46 for total
potential drug interactions and a mean of 0.54 for potential drugs in the EMR with those
not previously in the EMR.

•

Those 12 who brought their medications to the office for reconciliation had a mean of
0.58 for total potential drug interactions and a mean of 0.33 for potential drug interactions
between drugs in the EMR with those not previously in the EMR (see Table 6).
Table 6. Potential Drug Interactions In-Home vs. In-Office

Overall results reflected that those who were reconciled at home had more missing
medications (mean 5.54 vs 3.42) in the EMR as well as a higher potential for total drug
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interactions (mean 1.46 vs 0.54). Those results highlight why patients are at such increase risk
when medication reconciliation is not performed correctly and why the World Health
Organization named it as one of five top patient safety strategies.
Suggestions and Future Recommendations
There was clearly a practice gap in this mental health practice in the area of medication
reconciliation. Not only was there a practice gap but there was also a knowledge gap amongst
the staff and one could even say, among the organization as a whole. Although reconciling
medications was a part of admitting new patients to the practice, it was not executed thoroughly
and completely to create the “one source of truth.” With education, however, the staff at the
practice were found to be very receptive about improving the process; or as Lippitt describes it,
they had to motivation and capacity to change.
Conclusion
Increasing rates of chronic illness have resulted in an increase in the complexity of
medication regimens. Patients are having medications prescribed in acute care facilities, skilled
nursing facilities and in multiple outpatient settings, thereby opening up the potential for an
increased risk of adverse drug events (ADE). Adverse drug reactions represent a serious and in
many cases, preventable, public health problem that can lead to illness, disability, and death.
Medication reconciliation is a process that can help reduce the potential for adverse drug events.
When medications are reconciled accurately in an outpatient setting, a best possible medication
history is created.
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Appendix A

Lippitt’s Phases of Change Theory

Mitchell, G. (2013). Selecting the best theory to implement planned change. Nursing
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MEDICATIONS
Start
Date

Name of Medication

mm/dd/yy

Brand and Generic name
(If available)

Patient Name:

Appendix B
Prescribed By

Dosage

When is the
Medication
Taken

mg/ units/
puffs/ drops

How many times
per day?
Morning and/or
night? After
meals?

Purpose

Danger Signs*

Notes/ Changes

Call Immediately if
you experience any
of these signs

Drugs and/or food that may cause
interactions. Date list was
reviewed/updated
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Appendix C

Citation

Sample/location

Design

Outcomes/results

Nassaralla, C.,
Naessens, J., Hunt,
V., Bhagra, A.,
Chaudhry, R.,
Hansen, M., &
Tulledge-Scheitel,
S. (2008).
Medication
reconciliaiton in
ambulatory care:
attempts at
improvement.
Quality Safety
Healthcare, 402407.
doi:10.1136/qshc.20
07.024513

Sample:
pre and post
intervention
N=325

Patients were
selected by using
random numbers

Completeness of
medication lists
improved from
20.4% preintervention to 50.4%
post-intervention

Location:
Four academic
ambulatory, primary
care medicine
clinics

Patients received
an LPN-guided
‘patient
awareness’
intervention about
the medication
reconciliation
process
Impact of
intervention
assessed postintervention

Strengths/weakness

Strengths:
Few patients met the
exclusion criteria
It’s possible to improve
accuracy of medication
lists with low a
technology solution
Patient participation
Weaknesses:
in the medication
reconciliation process No control group to
compare with postincreased from
13.9% to 33%; lastly, intervention group
medication list
Conducted among four
accuracy improved
practice settings that may
from 11.5% to 29%.
not generalize to other
settings

Evidence Level
3

B
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Citation

Sample/location

Design

Outcomes/results

Strengths/weakness

Evidence Level

Keogh, C., Kachalia,
A., Fiumara, K.,
Goulart, D., Coblyn,
J., & Desai, S.
(2016). Ambulatory
medication
reconciliation:
Using a
collaborative
approach to process
improvement at an
academic medical
center. The Joint
Commision, 186192.

22,884 patient visits
per month three
months of 2013;
256,800 patient
visits nine months of
2014 (1 yr. study
period).

Pilot study and
Institutional
collaborative
improvement
project
Three levels
(rigorous,
modified, less
intensive) of
interventions that
centered on staff
education were
implemented

From pre to postintervention,
improvement from
71% to 90% in
specialty practices
and from 62% to
91% in primary
care practices and
across all
ambulatory
practices increased
from 81% to 90%.

Strengths:
Use of a collaborative
model that aligned with
policy, EHR tools and
reliable electronic
measurement

3

Location:
148 Brigham and
Women’s Hospital
ambulatory care
practices in Boston

Weaknesses:
Pressure on provider
time affected attendance
in collaborative sessions
Financial incentive added
in final phases

B
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Citation

Sample/location

Design

Outcomes/results

Strengths/weakness

Evidence Level

Milone, A.,
Philbrick, A., &
Harris, I. F. (2014).
Medication
reconciliation by
clinical pharmacists
in an outpatient
family medicine
clinic. Journal of
the American
Pharmacists
Association, 181187.
doi:10.1331/JAPhA
.2014.12230

N=327

Non-experimental
research is the label
given to a study

Pharmacist-led
intervention.
Before seeing the
physician, the
clinical pharmacist
consulted with each
patient and
reviewed their
medication list and
made corrections as
necessary.
2,167 discrepancies
were identified and
resolved; 51.1%
were clinically
important

Strengths:
High number of
patients seen,
resulting in large
number of
discrepancies and
ability to categorize
them
Weaknesses:
Time spent on each
visit not recorded
Subjective nature of
data points (patient
knowledge status,
clinical importance of
discrepancy

3

Location:
Family Medicine
Clinic in St. Paul,
MN

B
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Citation

Sample/location

Design

Outcomes/results

Strengths/weakness

Sarzynski, E., Luz,
C., Rios-Bedoya,
C., & Zhou, S.
(2014).
Considerations for
using the 'brown
bag' strategy to
reconcile
medications during
routine outpatient
office visits.
Quality in Primary
Care, 177-187.

N=46; cognitively
intact elders
Mean age 79.8 yrs

Cross sectional
pilot study

61% of ‘brown
baggers’ (BB) did
not bring all their
medications to their
appointment
6.5% of chart
medication lists
were correct
BBs reported
having had a
comprehensive
med review vs.
NBB which
suggests the value
of the BB strategy

Strengths:
3
Brown baggers had
comprehensive med
reviews
Weaknesses:
Low compliance with
brown bagging
Partial brown baggers
not differentiated
from those who
brought all meds
Time-consuming
process

Universityaffiliated
community
geriatric clinic

Half of the
participants were
asked to ‘brown
bag' (bring their
medication bottles
with them to the
appointment)
The other half were
‘non-brown
baggers.'

Evidence Level
C
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Citation

Sample/location

Design

Outcomes/results

Strengths/weakness

Evidence Level

Vejar, M., Makic,
M., & KotthoffBurrell, E. (2014).
Medication
management for
elderly patients in
an academic
primary care
setting: A quality
improvement
project. Journal of
the American
Association of
Nurse Practitioners,
72-78.
doi:10.1002123276924.12121

1580 chart audits
903 patient
questionnaires

Quality
improvement
project

Medication
reconciliation
compliance
increased from
64% to 96%

Strengths:
Increased awareness
among providers of
importance of med
management in PCP
setting

3

Patients who
brought their
medications to visit
increased from 0%
to 64%
Senior clinic within
a large academic
setting

Improved med
management enabled
the clinic to reach the
national standards for
medication
reconciliation

B

MEDICATION RECONCILIATION

39
Appendix D

MEDICATION RECONCILIATION

40
Appendix E
Timeline

Task
Patient
selection
Intervention

Data analysis
and final
report

October

November

X

X

December

January

X

X

February

March

April

X

X

X

